NeuroOne Medical Technologies Corporation·Healthcare

First Choice Healthcare Solutions (OTCMKTS:FCHS - Get Free Report) and NeuroOne Medical Technologies (NASDAQ: NMTC - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations. Valuation and Earnings This

NeuroOne Medical Technologies Corporation (NMTC) Discusses Platform Technology Advancements and Growth Plans for Neurological Device Applications Transcript

Shares of NeuroOne Medical Technologies Corporation (NASDAQ: NMTC - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the five analysts that are covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, three have given a buy recommendation and one has assigned a strong

NeuroOne Medical Technologies Corporation (NMTC) Q1 2026 Earnings Call Transcript

Aclarion (NASDAQ: ACON - Get Free Report) and NeuroOne Medical Technologies (NASDAQ: NMTC - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, profitability, analyst recommendations, valuation, risk and institutional ownership. Institutional and Insider Ownership 7.5% of Aclarion

Cannlabs (OTCMKTS:CANL - Get Free Report) and NeuroOne Medical Technologies (NASDAQ: NMTC - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, valuation, profitability, dividends and earnings. Profitability This table compares Cannlabs and NeuroOne Medical
NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. The company is based in Eden Prairie, Minnesota.